3653 results for «267»
3653 results
Transcatheter tricuspid valve interventions: procedural considerations
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session on transcatheter tricuspid valve interventions to know more about what to do before planning tricuspid regurgitation interventions, to understand when to perform a right heart catheterisation and to learn how to solve complications during interventions.
Mixed VHD: how to manage?
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session to learn more about aortic stenosis and aortic regurgitation: how to diagnose these conditions, how to select patients for surgical or transcatheter interventions, and how to treat them.
Endocarditis: what can we suggest for the upcoming ESC guidelines?
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch this session to learn more about the various challenges in treating patients with endocarditis, to understand how to better diagnose valve endocarditis and to discover new transcatheter interventions after endocarditis.
The challenge of aortic regurgitation: better imaging for better clinical practice
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch this session to learn about the challenges of diagnosing aortic regurgitation and how to overcome them, to better understand the right timing for intervention based on available evidence, and to discover what tools exist to more accurately assess the severity of aortic regurgitation.
Contemporary imaging trends in aortic stenosis - How to diagnose
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch these presentation to know all about the latest diagnostic tools in aortic stenosis, to learn how to use 3D in aortic stenosis and to understand when 3D echo and exercise echo are useful.
Imaging before and after TAVI - How to treat
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session on imaging before and after TAVI to learn how to better select patients for TAVI, to understand how to treat paravalvular leak and to know how to deal with and prevent valve thrombosis.
Where are we going? The symptomatic patient with moderate aortic stenosis
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch these presentations on symptomatic patient with moderate aortic stenosis to learn to evaluate outcomes after TAVI, to better assess aortic stenosis and LV function, and to expand your knowledge in infiltrative diseases.
Diagnosis of disease type and of disease severity
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session to learn how to better assess mitral regurgitation and how to better diagnose mitral stenosis through imaging.
High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry
25 Feb 2021
The study aimed to evaluate the validity of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria for East Asian patients undergoing contemporary percutaneous coronary intervention (PCI) from the PENDULUM registry.
Authors :
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial
29 Mar 2025
Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.
Author
Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial
31 Mar 2025
Mirvat Alasnag provides her take on the Altshock-2 randomized clinical trial which was presented by Alice Sacco at ACC.25 in Chicago.
Author
The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial
25 Oct 2023
Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
